Loading…
Vera Therapeutics, Inc. is projected to rise to $42.27 by 2027, a +28% move from its current price of $33.05. VERA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $32.13 | $33.04 | $33.97 | -0.04% |
| Aug 2 | $31.75 | $33.02 | $34.35 | -0.08% |
| Aug 3 | $31.46 | $33.01 | $34.64 | -0.12% |
| Aug 4 | $31.21 | $33.00 | $34.88 | -0.16% |
| Aug 5 | $31.00 | $32.98 | $35.10 | -0.20% |
| Aug 6 | $30.80 | $32.97 | $35.29 | -0.24% |
| Aug 7 | $30.62 | $32.96 | $35.47 | -0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $30.62 | $32.96 | $35.47 | -0.28% |
| Week 2 | $29.62 | $32.86 | $36.46 | -0.57% |
| Week 3 | $28.85 | $32.77 | $37.22 | -0.85% |
| Week 4 | $28.21 | $32.68 | $37.85 | -1.13% |
| Week 5 | $27.64 | $32.58 | $38.41 | -1.41% |
| Week 6 | $27.13 | $32.49 | $38.90 | -1.69% |
| Week 7 | $26.67 | $32.40 | $39.36 | -1.97% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Vera Therapeutics, Inc. is a clinical stage biotechnology company focused on the development and commercialization of transformative treatments for patients with immunological diseases. The company offers atacicept, a fully humanized TACI-Fc fusion protein that binds BAFF and APRIL, which is self-administered at home as a subcutaneous injection and is being evaluated for immunoglobulin A nephropathy (IgAN) and other autoimmune kidney diseases.
Vera is also developing MAU868, a human monoclonal antibody for BK viremia infections that has completed phase 2 clinical trial, and VT-109, a BAFF/APRIL dual-inhibitor BCMA molecule to treat B cell mediated autoimmune diseases. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc.
in April 2020. Vera was incorporated in 2016 and is headquartered in Brisbane, California.
Vera Therapeutics, Inc. (VERA) is a healthcare stock currently priced at $33.32 with a market capitalization of $2.39B, and it ranks 1839. The current price places Vera near the forecast 2026 average of $33.32, suggesting alignment with near-term expectations.
The long-run outlook shows substantial upside, with the average price forecast rising through the late 2020s and into the 2030s and beyond. By 2030, the average price is forecast at $51.41, and by 2050 the average is forecast at $197.52, with a projected ROI of 492.8% in 2050. This path implies meaningful upside relative to the present level, though near-term volatility and risk remain notable.
A major floor 22.6% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.6% away) — a key level to hold.
The nearest ceiling, 30.6% above — a clean break opens room to run.
A major ceiling 41.8% above — clearing it would confirm fresh momentum.
Key VERA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of VERA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $33.90 | Sell | $33.89 | Sell |
| MA 10 | $35.46 | Sell | $35.41 | Sell |
| MA 20 | $38.60 | Sell | $36.94 | Sell |
| MA 50 | $36.79 | Sell | $37.60 | Sell |
| MA 100 | $38.05 | Sell | $37.94 | Sell |
| MA 200 | $38.93 | Sell | $37.12 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 33.02 | Neutral |
| Stoch RSI (14) | 8.25 | Buy |
| CCI (20) | -117.74 | Sell |
| Williams %R (14) | -94.92 | Info |
| MACD (12,26,9) | -0.96 | Sell |
| ROC (12) | -23.37 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 5.08 | Buy |
| TRIX (15) | -0.09 | Sell |
| Awesome (5,34) | -4.50 | Sell |
| Ultimate (7,14,28) | 20.20 | Buy |
| Momentum (10) | -6.07 | Sell |
| Aroon Osc (25) | -84.00 | Sell |
| Hull MA (9) | 32.37 | Buy |
| ADX (14) | 24.99 | Sell |
| ATR (14) | 0.96 | Info |
The 30-day technical picture is bearish. The RSI(14) is 40, with the 50-day simple moving average at $37.11 and the 200-day simple moving average at $38.86. Near-term support sits at $33.65 and resistance at $43.15. The stock traded within a 30-day range of $27.57 to $40.28, and annualized volatility stands around 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $31.26 | $33.05 | $39.68 | 0% | Neutral | |
| $33.65 | $42.27 | $56.16 | +28% | Bullish | |
| $35.08 | $45.36 | $62.61 | +37% | Bullish | |
| $34.59 | $45.80 | $65.12 | +39% | Bullish | |
| $35.91 | $48.55 | $70.77 | +47% | Bullish | |
| $35.52 | $48.95 | $72.92 | +48% | Bullish | |
| $39.45 | $55.34 | $84.06 | +67% | Bullish | |
| $45.88 | $65.44 | $101.16 | +98% | Bullish | |
| $48.34 | $70.04 | $110.04 | +112% | Bullish | |
| $50.56 | $74.38 | $118.62 | +125% | Bullish | |
| $70.18 | $110.57 | $187.75 | +235% | Bullish | |
| $96.53 | $171.23 | $318.49 | +418% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $31.26 | $33.05 | $38.53 | +0.00% |
| August 2026 | $27.23 | $31.97 | $38.42 | -3.27% |
| September 2026 | $26.90 | $31.85 | $38.80 | -0.38% |
| October 2026 | $27.31 | $32.56 | $40.10 | +2.25% |
| November 2026 | $26.81 | $32.14 | $39.92 | -1.31% |
| December 2026 | $26.30 | $31.70 | $39.68 | -1.37% |
Click any year to see its month-by-month VERA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The VERA price prediction for 2026 points to an average of $33.05 (low $31.26, high $39.68) — a potential gain of 0% on today's $33.05. A consolidation phase looks the most probable path here.
In 2027, VERA is projected to trade between $33.65 and $56.16, averaging $42.27 — a potential gain of +28% from today's $33.05. That is up +28% on the projected 2026 average. Momentum favours further upside here.
Vera Therapeutics, Inc.'s 2028 outlook centres on $45.36, within a $35.08 to $62.61 range. That is up +7% on the projected 2027 average. That marks a +37% change versus current levels. Buyers look set to stay in control over this stretch.
By 2029, VERA could reach as high as $65.12, with a base case around $45.80 and support toward $34.59 — roughly +39% from $33.05. Momentum favours further upside here.
Expect VERA to range from $35.91 to $70.77 through 2030. The $48.55 average target implies a +47% move from current prices. That is up +6% on the projected 2029 average. Buyers look set to stay in control over this stretch.
The VERA price prediction for 2031 points to an average of $48.95 (low $35.52, high $72.92) — a potential gain of +48% on today's $33.05. Momentum favours further upside here.
In 2032, VERA is projected to trade between $39.45 and $84.06, averaging $55.34 — a potential gain of +67% from today's $33.05. That is up +13% on the projected 2031 average. Buyers look set to stay in control over this stretch.
Vera Therapeutics, Inc.'s 2033 outlook centres on $65.44, within a $45.88 to $101.16 range. That is up +18% on the projected 2032 average. That marks a +98% change versus current levels. Momentum favours further upside here.
By 2034, VERA could reach as high as $110.04, with a base case around $70.04 and support toward $48.34 — roughly +112% from $33.05. Buyers look set to stay in control over this stretch.
Expect VERA to range from $50.56 to $118.62 through 2035. The $74.38 average target implies a +125% move from current prices. That is up +6% on the projected 2034 average. Momentum favours further upside here.
The VERA price prediction for 2040 points to an average of $110.57 (low $70.18, high $187.75) — a potential gain of +235% on today's $33.05. Buyers look set to stay in control over this stretch.
In 2050, VERA is projected to trade between $96.53 and $318.49, averaging $171.23 — a potential gain of +418% from today's $33.05. That is up +55% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in VERA today (≈ 30.257186 VERA) could be worth
$5,180.87
+$4,180.87 (+418%) by 2050 · US Dollar
Based on the average projected VERA price of $171.23 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in VERAwould be worth at today's price.
$1,000 invested in VERA on Jul 30, 2025 (≈ 47.415837 VERA) would be worth
$1,567.09
+$567.09 (+56.7%) today · 1.57× · US Dollar
Based on a VERA entry price of $21.09 vs. today's $33.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $36.35 | $909.22 | -9.1% |
| 1 month ago | $42.91 | $770.22 | -23.0% |
| 3 months ago | $35.2 | $938.92 | -6.1% |
| 6 months ago | $43.26 | $763.99 | -23.6% |
| 1 year ago | $21.09 | $1,567.09 | +56.7% |
| All time (5.0y) ago | $17.4 | $1,899.43 | +89.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our VERA forecast.
Our base-case forecast reaches $66.00 around 2034.
Implied market cap at $66.00: $4.74B
The multi-year forecast shows a bullish trajectory beginning in the later 2020s, with 2026 labeled as neutral and 2027 onward labeled bullish. In 2030, the forecasted min, avg, and max prices are $37.79, $51.41, and $75.48 respectively, with a 54.3% ROI and bullish sentiment. In 2040, the forecast expects $77.65 as the minimum, $123.96 as the average, and $212.81 as the maximum, with a 272% ROI and bullish sentiment.
In 2050, the forecast projects $109.24 as the minimum, $197.52 as the average, and $372.20 as the maximum, with a 492.8% ROI and bullish sentiment. These figures are estimates, not guarantees, and reflect potential paths for Vera Therapeutics, Inc. based on the stated forecast data.
Tap a question to reveal the answer.
For 2030 the forecast shows min $37.79, avg $51.41, max $75.48 with ROI 54.3% and bullish sentiment.
The forecast turns bullish from 2027 onward, with rising averages and positive ROI (e.g., 2027 avg $43.92, ROI 31.8%; 2028 avg $47.10, ROI 41.4%). These are estimates, not guarantees.
Yes—the 2033 forecast maximum is $111.92.
The 2026 forecast is min $31.26, avg $33.32, max $40.51.
The 2050 forecast shows min $109.24, avg $197.52, max $372.20 with ROI 492.8% and bullish sentiment.
Vera Therapeutics, Inc. Community Discussion
0Share your Vera Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.